Diagnostic Botulinum Sera Types A, B, C, E, F — Native Equine Lyophilized, for Biological Neutralization Reaction, TU 21.20.21-154-20401675-2019

Diagnostic Botulinum Sera Types A, B, C, E, F — Native Equine Lyophilized, for Biological Neutralization Reaction, TU 21.20.21-154-20401675-2019

Native equine lyophilized diagnostic sera for biological neutralization reaction according to TU 21.20.21-154-20401675-2019.

Version 1

Diagnostic Botulinum Serum Type A:

• Native equine serum, not less than 200 IU per ampoule (5 ampoules, lyophilizate derived from volume depending on specific activity).

Version 2

Diagnostic Botulinum Serum Type B:

• Native equine serum, not less than 100 IU per ampoule (5 ampoules, lyophilizate derived from volume depending on specific activity).

Version 3

Diagnostic Botulinum Serum Type C:

• Native equine serum, not less than 150 IU per ampoule (5 ampoules, lyophilizate derived from volume depending on specific activity).

Version 4

Diagnostic Botulinum Serum Type E:

• Native equine serum, not less than 200 IU per ampoule (5 ampoules, lyophilizate derived from volume depending on specific activity).

Version 5

Diagnostic Botulinum Serum Type F:

• Native equine serum, not less than 50 IU per ampoule (5 ampoules, lyophilizate derived from volume depending on specific activity).

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Diagnostic Botulinum Sera Types A, B, C, E, F — Native Equine Lyophilized, for Biological Neutralization Reaction, TU 21.20.21-154-20401675-2019, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.